{
    "name": "leuprolide",
    "comment": "Rx",
    "other_names": [
        "Lupron",
        "Lupron Depot",
        "Lupron Depot 3 Month",
        "Lupron Depot 4 Month",
        "Lupron Depot 6 Month",
        "Lupron Depot-Ped",
        "Eligard",
        "Fensolvi",
        "Camcevi",
        "Lutrate Depot"
    ],
    "classes": [
        "Antineoplastics",
        "GNRH Agonists"
    ],
    "source": "https://reference.medscape.com/drug/lupron-eligard-leuprolide-342221",
    "pregnancy": {
        "common": [
            "Contraindicated",
            "Based on animal data and mechanism of action, fetal harm may occur",
            "Insufficient data available to assess the risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes",
            "Exclude pregnancy in females of reproductive potential prior to initiation"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Associated with an increased risk of pregnancy complications",
                    "SC administration to rabbits during organogenesis caused embryofetal toxicity, decreased fetal weights, and a dose-dependent increase in major fetal abnormalities in animals at doses less recommended human dose based on body surface area using an estimated daily dose"
                ]
            },
            {
                "type": "Contraception",
                "description": [
                    "Females of reproductive potential: Not a contraceptive; if contraception is indicated, use a nonhormonal contraception during treatment "
                ]
            },
            {
                "type": "Infertility",
                "description": [
                    "Based on its pharmacodynamic effects of decreasing secretion of gonadal steroids, fertility is expected to be decreased during treatment",
                    "Clinical and pharmacologic studies in adults (>18 years) with leuprolide acetate and similar analogs have shown reversibility of fertility suppression when discontinued after continuous administration for periods of up to 24 weeks ",
                    "There is no evidence that pregnancy rates are affected following discontinuation",
                    "Animal studies (prepubertal and adult rats and monkeys) with leuprolide acetate and other GnRH analogs have shown functional recovery of fertility suppression"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No data available on presence of leuprolide acetate in either animal or human milk, effects on breastfed infants, or effects on milk production",
            "Developmental and health benefits of breastfeeding should be considered along with the motherâ€™s clinical need for therapy and any potential adverse effects on the breastfed infant therapy or from underlying maternal conditions"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity ",
                "Pregnancy"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "May cause fetal harm when administered to pregnant females"
            ],
            "specific": [
                {
                    "type": "Children and young adults",
                    "description": [
                        "During early phase of therapy, gonadotropins and sex steroids rise above baseline because of the initial stimulatory effect of the drug; therefore, an increase in clinical signs and symptoms of puberty including vaginal bleeding may be observed during the first weeks of therapy or after subsequent doses",
                        "Psychiatric adverse events or emotional lability, including crying, irritability, impatience, anger, and aggression, reported; many, but not all, patients had a history of psychiatric illness or other comorbidities with an increased risk of depression",
                        "Postmarketing reports of convulsions reported, including patients with or without a history of seizures, epilepsy, cerebrovascular disorders, central nervous system anomalies, and patients on concomitant medications associated with convulsions such as bupropion and SSRIs",
                        "Pseudotumor cerebri (idiopathic intracranial hypertension) reported in pediatric patients receiving GnRH agonists, including leuprolide acetate; monitor patients for signs and symptoms of pseudotumor cerebri, including headache, papilledema, blurred vision, diplopia, loss of vision, pain behind the eye or pain with eye movement, tinnitus, dizziness, and nausea"
                    ]
                },
                {
                    "type": "Adults",
                    "description": [
                        "Spinal cord compression reported; observe patients closely for weakness and paresthesias in first few weeks of therapy; observe patients with metastatic vertebral lesions closely",
                        "Tumor flare resulting from transient increases in testosterone, leading to bone pain, hematuria, bladder outlet obstruction, and neuropathy in prostate cancer patients reported during first few weeks of therapy",
                        "Closely observe patients for urinary tract obstruction and hematuria in first few weeks of therapy",
                        "Orchiectomy or luteinizing hormone agonists recommended as initial treatment for androgen deprivation in patients with advanced androgen sensitive prostate cancer",
                        "Decrease in bone density reported when drug used for >6 months; use caution if there are additional risk factors for bone loss, including corticosteroid therapy or chronic alcohol use",
                        "Worsening of endometriosis or uterine leiomyomata symptoms with therapy reported initially",
                        "Rare cases of pituitary apoplexy, frequently secondary to pituitary adenoma reported (onset 1hr to usually <2 weeks): may present as sudden headache, vomiting, visual or mental status changes and cardiovascular collapse (rare), requiring immediate medical attention",
                        "Worsening of glycemic control reported in men receiving GnRH agonists; monitor blood glucose and/or glycosylated hemoglobin (HbA1c) periodically in patients receiving a GnRH agonist and manage with current practice for treatment of hyperglycemia or diabetes",
                        "Prostate cancer symptoms may worsen during initial treatment period",
                        "Androgen deprivation therapy may prolong the QT/QTc interval; consider whether benefits of androgen deprivation outweighs potential risks in patients with congenital long QT syndrome, congestive heart failure, frequent electrolyte abnormalities, and patients taking drugs known to prolong the QT interval; correct electrolyte abnormalities and monitor ECG and electrolytes periodically",
                        "Men receiving GnRH agonists for prostate cancer have slightly increased risk of diabetes, heart attack, stroke, and sudden death",
                        "In women, duration of treatment with GnRH agonists not to exceed 1 year, except in treatment of breast cancer"
                    ]
                },
                {
                    "type": "Therapy for hormone receptor-positive breast cancer",
                    "description": [
                        "Ovarian suppression recommended for the following",
                        "Premenopausal women with higher-risk disease in addition to adjuvant endocrine therapy, ",
                        "Addition to adjuvant chemotherapy in premenopausal women with stage II or stage III breast cancers",
                        "Stage I or II breast cancers at higher risk of recurrence in addition to endocrine therapy, who might consider chemotherapy",
                        "Women with stage I disease, which does not require chemotherapy should receive endocrine therapy but not ovarian suppression",
                        "Women with node-negative cancers <1 cm (T1A< T1B) should receive endocrine therapy, but not ovarian suppression"
                    ]
                },
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "When using drug for management of endometriosis, combination use of norethindrone acetate (add-back therapy) is effective in reducing loss of BMD that occurs with leuprolide acetate; do not retreat with drug without combination norethindrone acetate; assess BMD before retreatment"
                    ]
                }
            ]
        }
    },
    "interactions": [
        {
            "classification_type": "Contraindicated",
            "interaction_with": "amiodarone",
            "description": {
                "common": "leuprolide increases toxicity of amiodarone by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "anagrelide",
            "description": {
                "common": "leuprolide increases toxicity of anagrelide by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "arsenic trioxide",
            "description": {
                "common": "leuprolide increases toxicity of arsenic trioxide by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "artemether",
            "description": {
                "common": "leuprolide increases toxicity of artemether by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "artemether/lumefantrine",
            "description": {
                "common": "leuprolide increases toxicity of artemether/lumefantrine by QTc interval. Contraindicated."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "citalopram",
            "description": {
                "common": "leuprolide increases toxicity of citalopram by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "disopyramide",
            "description": {
                "common": "leuprolide increases toxicity of disopyramide by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "dofetilide",
            "description": {
                "common": "leuprolide increases toxicity of dofetilide by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "dronedarone",
            "description": {
                "common": "leuprolide increases toxicity of dronedarone by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "eliglustat",
            "description": {
                "common": "leuprolide increases toxicity of eliglustat by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "escitalopram",
            "description": {
                "common": "leuprolide increases toxicity of escitalopram by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "fluoxetine",
            "description": {
                "common": "leuprolide increases toxicity of fluoxetine by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "ibutilide",
            "description": {
                "common": "leuprolide increases toxicity of ibutilide by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "iloperidone",
            "description": {
                "common": "leuprolide increases toxicity of iloperidone by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "lopinavir",
            "description": {
                "common": "leuprolide increases toxicity of lopinavir by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "lumefantrine",
            "description": {
                "common": "leuprolide increases toxicity of lumefantrine by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "mifepristone",
            "description": {
                "common": "leuprolide increases toxicity of mifepristone by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "nilotinib",
            "description": {
                "common": "leuprolide increases toxicity of nilotinib by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "paliperidone",
            "description": {
                "common": "leuprolide increases toxicity of paliperidone by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "pimozide",
            "description": {
                "common": "leuprolide increases toxicity of pimozide by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "procainamide",
            "description": {
                "common": "leuprolide increases toxicity of procainamide by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "quetiapine",
            "description": {
                "common": "leuprolide increases toxicity of quetiapine by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "quinidine",
            "description": {
                "common": "leuprolide increases toxicity of quinidine by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "sotalol",
            "description": {
                "common": "leuprolide increases toxicity of sotalol by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "tetrabenazine",
            "description": {
                "common": "leuprolide increases toxicity of tetrabenazine by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "thioridazine",
            "description": {
                "common": "leuprolide increases toxicity of thioridazine by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "toremifene",
            "description": {
                "common": "leuprolide increases toxicity of toremifene by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "vandetanib",
            "description": {
                "common": "leuprolide increases toxicity of vandetanib by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "vemurafenib",
            "description": {
                "common": "leuprolide increases toxicity of vemurafenib by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "ziprasidone",
            "description": {
                "common": "leuprolide increases toxicity of ziprasidone by QTc interval. Contraindicated. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "amisulpride",
            "description": {
                "common": "amisulpride and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug. ECG monitoring is recommended if coadministered."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "asenapine",
            "description": {
                "common": "asenapine and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "asenapine transdermal",
            "description": {
                "common": "asenapine transdermal and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "buprenorphine",
            "description": {
                "common": "buprenorphine and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "buprenorphine buccal",
            "description": {
                "common": "buprenorphine buccal and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "buprenorphine subdermal implant",
            "description": {
                "common": "buprenorphine subdermal implant and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "buprenorphine transdermal",
            "description": {
                "common": "buprenorphine transdermal and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "buprenorphine, long-acting injection",
            "description": {
                "common": "buprenorphine, long-acting injection and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "desflurane",
            "description": {
                "common": "desflurane and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "encorafenib",
            "description": {
                "common": "encorafenib and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "entrectinib",
            "description": {
                "common": "leuprolide and entrectinib both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "fexinidazole",
            "description": {
                "common": "fexinidazole and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug. Avoid coadministration of fexinidazole with drugs known to block potassium channels or prolong QT interval."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "glasdegib",
            "description": {
                "common": "leuprolide and glasdegib both increase  QTc interval. Avoid or Use Alternate Drug. If coadministration unavoidable, monitor for increased risk of QTc interval prolongation."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "inotuzumab",
            "description": {
                "common": "inotuzumab and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug. If unable to avoid concomitant use, obtain ECGs and electrolytes before and after initiation of any drug known to prolong QTc, and periodically monitor as clinically indicated during treatment."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "isoflurane",
            "description": {
                "common": "isoflurane and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "lefamulin",
            "description": {
                "common": "lefamulin and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "olanzapine",
            "description": {
                "common": "olanzapine and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "oxaliplatin",
            "description": {
                "common": "oxaliplatin and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "panobinostat",
            "description": {
                "common": "leuprolide and panobinostat both increase  QTc interval. Avoid or Use Alternate Drug. Panobinostat is known to significantly prolong QT interval. Panobinostat prescribing information states use with drugs known to prolong QTc is not recommended."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "pitolisant",
            "description": {
                "common": "leuprolide and pitolisant both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "sevoflurane",
            "description": {
                "common": "sevoflurane and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "siponimod",
            "description": {
                "common": "siponimod and leuprolide both increase  QTc interval. Avoid or Use Alternate Drug."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "albuterol",
            "description": {
                "common": "albuterol and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "alfuzosin",
            "description": {
                "common": "leuprolide and alfuzosin both increase  QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes"
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "apomorphine",
            "description": {
                "common": "leuprolide increases toxicity of apomorphine by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "arformoterol",
            "description": {
                "common": "leuprolide increases toxicity of arformoterol by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "aripiprazole",
            "description": {
                "common": "aripiprazole and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "atomoxetine",
            "description": {
                "common": "atomoxetine and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "azithromycin",
            "description": {
                "common": "leuprolide increases toxicity of azithromycin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "bedaquiline",
            "description": {
                "common": "leuprolide increases toxicity of bedaquiline by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ceritinib",
            "description": {
                "common": "leuprolide increases toxicity of ceritinib by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "chloroquine",
            "description": {
                "common": "leuprolide increases toxicity of chloroquine by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "chlorpromazine",
            "description": {
                "common": "leuprolide increases toxicity of chlorpromazine by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "cholera vaccine",
            "description": {
                "common": "leuprolide decreases effects of cholera vaccine by immunosuppressive effects; risk of infection. Modify Therapy/Monitor Closely. Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs and corticosteroids (used in greater than physiologic doses), may reduce the immune response to cholera vaccine."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ciprofloxacin",
            "description": {
                "common": "leuprolide increases toxicity of ciprofloxacin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "clarithromycin",
            "description": {
                "common": "leuprolide increases toxicity of clarithromycin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "clozapine",
            "description": {
                "common": "leuprolide increases toxicity of clozapine by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "crizotinib",
            "description": {
                "common": "leuprolide increases toxicity of crizotinib by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dasatinib",
            "description": {
                "common": "dasatinib and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "degarelix",
            "description": {
                "common": "leuprolide increases toxicity of degarelix by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dengue vaccine",
            "description": {
                "common": "leuprolide decreases effects of dengue vaccine by immunosuppressive effects; risk of infection. Use Caution/Monitor. Immunosuppressive therapies (eg, irradiation, antimetabolites, alkylating agents, cytotoxic drugs, corticosteroids [greater than physiologic doses]) may reduce immune response to dengue vaccine."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "deutetrabenazine",
            "description": {
                "common": "deutetrabenazine and leuprolide both increase  QTc interval. Use Caution/Monitor. At the maximum recommended dose, deutetrabenazine does not prolong QT interval to a clinically relevant extent. Certain circumstances may increase risk of torsade de pointes and/or sudden death in association with drugs that prolong the QTc interval (eg, bradycardia, hypokalemia or hypomagnesemia, coadministration with other drugs that prolong QTc interval, presence of congenital QT prolongation)."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dichlorphenamide",
            "description": {
                "common": "dichlorphenamide and leuprolide both decrease  serum potassium. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "dolasetron",
            "description": {
                "common": "leuprolide increases toxicity of dolasetron by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "donepezil",
            "description": {
                "common": "donepezil and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "doxepin",
            "description": {
                "common": "doxepin and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "droperidol",
            "description": {
                "common": "leuprolide increases toxicity of droperidol by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "efavirenz",
            "description": {
                "common": "efavirenz and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "eribulin",
            "description": {
                "common": "leuprolide increases toxicity of eribulin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "erythromycin base",
            "description": {
                "common": "leuprolide increases toxicity of erythromycin base by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "erythromycin ethylsuccinate",
            "description": {
                "common": "leuprolide increases toxicity of erythromycin ethylsuccinate by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "erythromycin lactobionate",
            "description": {
                "common": "leuprolide increases toxicity of erythromycin lactobionate by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "erythromycin stearate",
            "description": {
                "common": "leuprolide increases toxicity of erythromycin stearate by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ezogabine",
            "description": {
                "common": "leuprolide increases toxicity of ezogabine by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "fingolimod",
            "description": {
                "common": "leuprolide increases toxicity of fingolimod by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "flecainide",
            "description": {
                "common": "leuprolide increases toxicity of flecainide by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "fluconazole",
            "description": {
                "common": "leuprolide increases toxicity of fluconazole by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "formoterol",
            "description": {
                "common": "leuprolide increases toxicity of formoterol by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "fostemsavir",
            "description": {
                "common": "leuprolide and fostemsavir both increase  QTc interval. Use Caution/Monitor. QTc prolongation reported with higher than recommended doses of fostemsavir."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "gallium Ga 68 PSMA-11",
            "description": {
                "common": "leuprolide will decrease the level or effect of gallium Ga 68 PSMA-11 by  unspecified interaction mechanism. Modify Therapy/Monitor Closely. Androgen deprivation therapy and other therapies targeting the androgen pathway may result in changes in the uptake of gallium Ga 68 PSMA-11 in prostate cancer. The effect of ADT on the performance of gallium Ga 68 PSMA-11 is unknown."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "gemifloxacin",
            "description": {
                "common": "leuprolide increases toxicity of gemifloxacin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "gemtuzumab",
            "description": {
                "common": "leuprolide and gemtuzumab both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "gilteritinib",
            "description": {
                "common": "gilteritinib and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "granisetron",
            "description": {
                "common": "granisetron and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "haloperidol",
            "description": {
                "common": "leuprolide increases toxicity of haloperidol by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "hydroxyzine",
            "description": {
                "common": "hydroxyzine and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "indacaterol, inhaled",
            "description": {
                "common": "leuprolide increases toxicity of indacaterol, inhaled by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "itraconazole",
            "description": {
                "common": "itraconazole and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "lapatinib",
            "description": {
                "common": "leuprolide increases toxicity of lapatinib by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "lenvatinib",
            "description": {
                "common": "leuprolide and lenvatinib both increase  QTc interval. Use Caution/Monitor. Lenvatinib prescribing information recommends monitoring ECG closely when coadministered with QT prolonging drugs."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "levofloxacin",
            "description": {
                "common": "leuprolide increases toxicity of levofloxacin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "lithium",
            "description": {
                "common": "lithium and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "metformin",
            "description": {
                "common": "leuprolide decreases effects of metformin by pharmacodynamic antagonism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "methadone",
            "description": {
                "common": "leuprolide increases toxicity of methadone by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "mirtazapine",
            "description": {
                "common": "mirtazapine and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "moxifloxacin",
            "description": {
                "common": "leuprolide increases toxicity of moxifloxacin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ofloxacin",
            "description": {
                "common": "leuprolide increases toxicity of ofloxacin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ondansetron",
            "description": {
                "common": "leuprolide increases toxicity of ondansetron by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "osilodrostat",
            "description": {
                "common": "osilodrostat and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "osimertinib",
            "description": {
                "common": "leuprolide increases toxicity of osimertinib by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "oxaliplatin",
            "description": {
                "common": "oxaliplatin will increase the level or effect of leuprolide by  Other (see comment). Use Caution/Monitor. Monitor for ECG changes if therapy is initiated in patients with drugs known to prolong QT interval."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "pasireotide",
            "description": {
                "common": "leuprolide increases toxicity of pasireotide by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "pazopanib",
            "description": {
                "common": "leuprolide increases toxicity of pazopanib by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "pentamidine",
            "description": {
                "common": "leuprolide increases toxicity of pentamidine by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "perflutren",
            "description": {
                "common": "leuprolide increases toxicity of perflutren by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "primaquine",
            "description": {
                "common": "primaquine and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "propafenone",
            "description": {
                "common": "leuprolide increases toxicity of propafenone by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ranolazine",
            "description": {
                "common": "leuprolide increases toxicity of ranolazine by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "romidepsin",
            "description": {
                "common": "leuprolide increases toxicity of romidepsin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "saquinavir",
            "description": {
                "common": "leuprolide increases toxicity of saquinavir by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "sertraline",
            "description": {
                "common": "sertraline and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "siponimod",
            "description": {
                "common": "siponimod and leuprolide both increase  immunosuppressive effects; risk of infection. Use Caution/Monitor. Caution if coadministered because of additive immunosuppressive effects during such therapy and in the weeks following administration. When switching from drugs with prolonged immune effects, consider the half-life and mode of action of these drugs to avoid unintended additive immunosuppressive effects."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "solifenacin",
            "description": {
                "common": "solifenacin and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "sorafenib",
            "description": {
                "common": "leuprolide increases toxicity of sorafenib by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "sunitinib",
            "description": {
                "common": "leuprolide increases toxicity of sunitinib by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "tacrolimus",
            "description": {
                "common": "tacrolimus and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "telavancin",
            "description": {
                "common": "leuprolide increases toxicity of telavancin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "trazodone",
            "description": {
                "common": "leuprolide increases toxicity of trazodone by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "triclabendazole",
            "description": {
                "common": "triclabendazole and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "valbenazine",
            "description": {
                "common": "valbenazine and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "voriconazole",
            "description": {
                "common": "leuprolide increases toxicity of voriconazole by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "vorinostat",
            "description": {
                "common": "vorinostat and leuprolide both increase  QTc interval. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "maitake",
            "description": {
                "common": "maitake increases effects of leuprolide by pharmacodynamic synergism. Minor/Significance Unknown. Maitake mushroom has anti-tumor effects (animal/in vitro research)."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "taurine",
            "description": {
                "common": "leuprolide decreases levels of taurine by unspecified interaction mechanism. Minor/Significance Unknown."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Injection site pain",
            "percent": "31"
        },
        {
            "name": "Nasopharyngitis",
            "percent": "22"
        },
        {
            "name": "Pyrexia",
            "percent": "17"
        },
        {
            "name": "Headache",
            "percent": "16"
        },
        {
            "name": "Cough",
            "percent": "13"
        },
        {
            "name": "Injection site reactions including abscess",
            "percent": "37"
        },
        {
            "name": "Emotional lability",
            "percent": "19"
        },
        {
            "name": "Acne",
            "percent": "13"
        },
        {
            "name": "seborrhea",
            "percent": "13"
        },
        {
            "name": "Vaginitis",
            "percent": "12"
        },
        {
            "name": "vaginal bleeding or discharge",
            "percent": "12"
        },
        {
            "name": "Rash including erythema multiforme",
            "percent": "11"
        },
        {
            "name": "General pain",
            "percent": "19-21"
        },
        {
            "name": "Headache",
            "percent": "58.5"
        },
        {
            "name": "Injection site pain",
            "percent": "26.6"
        },
        {
            "name": "Hot flashes",
            "percent": "20.2"
        },
        {
            "name": "sweats",
            "percent": "16"
        },
        {
            "name": "General pain",
            "percent": "14.9"
        },
        {
            "name": "Testicular atrophy",
            "percent": "13.8"
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": "11.7"
        },
        {
            "name": "Urinary disorders",
            "percent": "9"
        },
        {
            "name": "Injection site reaction",
            "percent": "9"
        },
        {
            "name": "Joint disorders",
            "percent": "8"
        },
        {
            "name": "Abdominal pain",
            "percent": "6"
        },
        {
            "name": "Injection site erythema",
            "percent": "6"
        },
        {
            "name": "Nausea",
            "percent": "6"
        },
        {
            "name": "Constipation",
            "percent": "6"
        },
        {
            "name": "Vomiting",
            "percent": "6"
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": "5"
        },
        {
            "name": "Bronchospasm",
            "percent": "2"
        },
        {
            "name": "Productive cough",
            "percent": "2"
        },
        {
            "name": "Hot flush",
            "percent": "2"
        },
        {
            "name": "Emotional disorder",
            "percent": "9"
        },
        {
            "name": "Irritability",
            "percent": "2"
        },
        {
            "name": "General",
            "percent": "7"
        },
        {
            "name": "Sweating",
            "percent": "2-7"
        },
        {
            "name": "insomnia",
            "percent": "5"
        },
        {
            "name": "syncope",
            "percent": "2"
        },
        {
            "name": "rigors",
            "percent": "5"
        },
        {
            "name": "weakness",
            "percent": "9.6"
        },
        {
            "name": "lethargy Gastrointestinal",
            "percent": "8.5"
        },
        {
            "name": "Flatulence",
            "percent": "8.5"
        },
        {
            "name": "constipation",
            "percent": "7.4"
        },
        {
            "name": "dyspepsia Hematologic",
            "percent": "6.4"
        },
        {
            "name": "Decreased red blood cell count",
            "percent": "6.4"
        },
        {
            "name": "hematocrit and hemoglobin Metabolic",
            "percent": "6.4"
        },
        {
            "name": "Weight gain Musculoskeletal",
            "percent": "5"
        },
        {
            "name": "Tremor",
            "percent": "2"
        },
        {
            "name": "backache",
            "percent": null
        },
        {
            "name": "joint pain",
            "percent": null
        },
        {
            "name": "muscle atrophy",
            "percent": null
        },
        {
            "name": "limb pain Nervous",
            "percent": null
        },
        {
            "name": "Disturbance of smell and taste",
            "percent": null
        },
        {
            "name": "depression",
            "percent": null
        },
        {
            "name": "vertigo Psychiatric",
            "percent": null
        },
        {
            "name": "Insomnia",
            "percent": null
        },
        {
            "name": "depression",
            "percent": null
        },
        {
            "name": "loss of libido Renal",
            "percent": null
        },
        {
            "name": "urinary",
            "percent": null
        },
        {
            "name": "Difficulties with urination",
            "percent": null
        },
        {
            "name": "pain on urination",
            "percent": null
        },
        {
            "name": "scanty urination",
            "percent": null
        },
        {
            "name": "bladder spasm",
            "percent": null
        },
        {
            "name": "blood in urine",
            "percent": null
        },
        {
            "name": "urinary retention",
            "percent": null
        },
        {
            "name": "urinary urgency",
            "percent": null
        },
        {
            "name": "incontinence",
            "percent": null
        },
        {
            "name": "nocturia",
            "percent": null
        },
        {
            "name": "nocturia aggravated Reproductive",
            "percent": null
        },
        {
            "name": "urogenital",
            "percent": null
        },
        {
            "name": "Testicular soreness",
            "percent": null
        },
        {
            "name": "pain",
            "percent": null
        },
        {
            "name": "impotence",
            "percent": null
        },
        {
            "name": "decreased libido",
            "percent": null
        },
        {
            "name": "gynecomastia",
            "percent": null
        },
        {
            "name": "breast soreness",
            "percent": null
        },
        {
            "name": "tenderness",
            "percent": null
        },
        {
            "name": "testicular atrophy",
            "percent": null
        },
        {
            "name": "erectile dysfunction",
            "percent": null
        },
        {
            "name": "penile disorder",
            "percent": null
        },
        {
            "name": "reduced penis size Skin",
            "percent": null
        },
        {
            "name": "Alopecia",
            "percent": null
        },
        {
            "name": "clamminess",
            "percent": null
        },
        {
            "name": "night sweats",
            "percent": null
        },
        {
            "name": "sweating increased Vascular",
            "percent": null
        },
        {
            "name": "Hypertension",
            "percent": null
        },
        {
            "name": "hypotension",
            "percent": null
        },
        {
            "name": "General",
            "percent": null
        },
        {
            "name": "Sweating",
            "percent": null
        },
        {
            "name": "insomnia",
            "percent": null
        },
        {
            "name": "syncope",
            "percent": null
        },
        {
            "name": "rigors",
            "percent": null
        },
        {
            "name": "weakness",
            "percent": null
        },
        {
            "name": "lethargy",
            "percent": null
        },
        {
            "name": "Gastrointestinal",
            "percent": null
        },
        {
            "name": "Flatulence",
            "percent": null
        },
        {
            "name": "constipation",
            "percent": null
        },
        {
            "name": "dyspepsia",
            "percent": null
        },
        {
            "name": "Hematologic",
            "percent": null
        },
        {
            "name": "Decreased red blood cell count",
            "percent": null
        },
        {
            "name": "hematocrit and hemoglobin",
            "percent": null
        },
        {
            "name": "Metabolic",
            "percent": null
        },
        {
            "name": "Weight gain",
            "percent": null
        },
        {
            "name": "Musculoskeletal",
            "percent": null
        },
        {
            "name": "Tremor",
            "percent": null
        },
        {
            "name": "backache",
            "percent": null
        },
        {
            "name": "joint pain",
            "percent": null
        },
        {
            "name": "muscle atrophy",
            "percent": null
        },
        {
            "name": "limb pain",
            "percent": null
        },
        {
            "name": "Nervous",
            "percent": null
        },
        {
            "name": "Disturbance of smell and taste",
            "percent": null
        },
        {
            "name": "depression",
            "percent": null
        },
        {
            "name": "vertigo",
            "percent": null
        },
        {
            "name": "Psychiatric",
            "percent": null
        },
        {
            "name": "Insomnia",
            "percent": null
        },
        {
            "name": "depression",
            "percent": null
        },
        {
            "name": "loss of libido",
            "percent": null
        },
        {
            "name": "Renal",
            "percent": null
        },
        {
            "name": "urinary",
            "percent": null
        },
        {
            "name": "Difficulties with urination",
            "percent": null
        },
        {
            "name": "pain on urination",
            "percent": null
        },
        {
            "name": "scanty urination",
            "percent": null
        },
        {
            "name": "bladder spasm",
            "percent": null
        },
        {
            "name": "blood in urine",
            "percent": null
        },
        {
            "name": "urinary retention",
            "percent": null
        },
        {
            "name": "urinary urgency",
            "percent": null
        },
        {
            "name": "incontinence",
            "percent": null
        },
        {
            "name": "nocturia",
            "percent": null
        },
        {
            "name": "nocturia aggravated",
            "percent": null
        },
        {
            "name": "Reproductive",
            "percent": null
        },
        {
            "name": "urogenital",
            "percent": null
        },
        {
            "name": "Testicular soreness",
            "percent": null
        },
        {
            "name": "pain",
            "percent": null
        },
        {
            "name": "impotence",
            "percent": null
        },
        {
            "name": "decreased libido",
            "percent": null
        },
        {
            "name": "gynecomastia",
            "percent": null
        },
        {
            "name": "breast soreness",
            "percent": null
        },
        {
            "name": "tenderness",
            "percent": null
        },
        {
            "name": "testicular atrophy",
            "percent": null
        },
        {
            "name": "erectile dysfunction",
            "percent": null
        },
        {
            "name": "penile disorder",
            "percent": null
        },
        {
            "name": "reduced penis size",
            "percent": null
        },
        {
            "name": "Skin",
            "percent": null
        },
        {
            "name": "Alopecia",
            "percent": null
        },
        {
            "name": "clamminess",
            "percent": null
        },
        {
            "name": "night sweats",
            "percent": null
        },
        {
            "name": "sweating increased",
            "percent": null
        },
        {
            "name": "Vascular",
            "percent": null
        },
        {
            "name": "Hypertension",
            "percent": null
        },
        {
            "name": "hypotension",
            "percent": null
        },
        {
            "name": "Vasodilation",
            "percent": null
        },
        {
            "name": "Body as a whole",
            "percent": null
        },
        {
            "name": "Aggravation of preexisting tumor and decreased vision",
            "percent": null
        },
        {
            "name": "allergic reaction",
            "percent": null
        },
        {
            "name": "body odor",
            "percent": null
        },
        {
            "name": "fever",
            "percent": null
        },
        {
            "name": "flu syndrome",
            "percent": null
        },
        {
            "name": "hypertrophy",
            "percent": null
        },
        {
            "name": "infection Cardiovascular system",
            "percent": null
        },
        {
            "name": "Bradycardia",
            "percent": null
        },
        {
            "name": "hypertension",
            "percent": null
        },
        {
            "name": "peripheral vascular disorder",
            "percent": null
        },
        {
            "name": "syncope Digestive System",
            "percent": null
        },
        {
            "name": "Constipation",
            "percent": null
        },
        {
            "name": "dyspepsia",
            "percent": null
        },
        {
            "name": "dysphagia",
            "percent": null
        },
        {
            "name": "gingivitis",
            "percent": null
        },
        {
            "name": "increased appetite",
            "percent": null
        },
        {
            "name": "nausea",
            "percent": null
        },
        {
            "name": "vomiting Endocrine system",
            "percent": null
        },
        {
            "name": "Accelerated sexual maturity",
            "percent": null
        },
        {
            "name": "feminization",
            "percent": null
        },
        {
            "name": "goiter Hemic and lymphatic system",
            "percent": null
        },
        {
            "name": "Purpura Metabolic and nutritional disorders",
            "percent": null
        },
        {
            "name": "Growth retarded",
            "percent": null
        },
        {
            "name": "peripheral edema",
            "percent": null
        },
        {
            "name": "weight gain Musculoskeletal system",
            "percent": null
        },
        {
            "name": "Arthralgia",
            "percent": null
        },
        {
            "name": "joint disorder",
            "percent": null
        },
        {
            "name": "myalgia",
            "percent": null
        },
        {
            "name": "myopathy Nervous system",
            "percent": null
        },
        {
            "name": "Hyperkinesia",
            "percent": null
        },
        {
            "name": "somnolence Psychiatric system",
            "percent": null
        },
        {
            "name": "Depression",
            "percent": null
        },
        {
            "name": "nervousness Respiratory system",
            "percent": null
        },
        {
            "name": "Asthma",
            "percent": null
        },
        {
            "name": "epistaxis",
            "percent": null
        },
        {
            "name": "pharyngitis",
            "percent": null
        },
        {
            "name": "rhinitis",
            "percent": null
        },
        {
            "name": "sinusitis Integumentary system",
            "percent": null
        },
        {
            "name": "skin and appendages",
            "percent": null
        },
        {
            "name": "Alopecia",
            "percent": null
        },
        {
            "name": "hair disorder",
            "percent": null
        },
        {
            "name": "hirsutism",
            "percent": null
        },
        {
            "name": "leukoderma",
            "percent": null
        },
        {
            "name": "nail disorder",
            "percent": null
        },
        {
            "name": "skin hypertrophy Urogenital system",
            "percent": null
        },
        {
            "name": "Cervix disorder",
            "percent": null
        },
        {
            "name": "neoplasm",
            "percent": null
        },
        {
            "name": "dysmenorrhea",
            "percent": null
        },
        {
            "name": "gynecomastia",
            "percent": null
        },
        {
            "name": "breast disorders",
            "percent": null
        },
        {
            "name": "menstrual disorder",
            "percent": null
        },
        {
            "name": "urinary incontinence Laboratory abnormality",
            "percent": null
        },
        {
            "name": "Antinuclear antibody present and increased sedimentation rate",
            "percent": null
        },
        {
            "name": "Body as a whole",
            "percent": null
        },
        {
            "name": "Aggravation of preexisting tumor and decreased vision",
            "percent": null
        },
        {
            "name": "allergic reaction",
            "percent": null
        },
        {
            "name": "body odor",
            "percent": null
        },
        {
            "name": "fever",
            "percent": null
        },
        {
            "name": "flu syndrome",
            "percent": null
        },
        {
            "name": "hypertrophy",
            "percent": null
        },
        {
            "name": "infection",
            "percent": null
        },
        {
            "name": "Cardiovascular system",
            "percent": null
        },
        {
            "name": "Bradycardia",
            "percent": null
        },
        {
            "name": "hypertension",
            "percent": null
        },
        {
            "name": "peripheral vascular disorder",
            "percent": null
        },
        {
            "name": "syncope",
            "percent": null
        },
        {
            "name": "Digestive System",
            "percent": null
        },
        {
            "name": "Constipation",
            "percent": null
        },
        {
            "name": "dyspepsia",
            "percent": null
        },
        {
            "name": "dysphagia",
            "percent": null
        },
        {
            "name": "gingivitis",
            "percent": null
        },
        {
            "name": "increased appetite",
            "percent": null
        },
        {
            "name": "nausea",
            "percent": null
        },
        {
            "name": "vomiting",
            "percent": null
        },
        {
            "name": "Endocrine system",
            "percent": null
        },
        {
            "name": "Accelerated sexual maturity",
            "percent": null
        },
        {
            "name": "feminization",
            "percent": null
        },
        {
            "name": "goiter",
            "percent": null
        },
        {
            "name": "Hemic and lymphatic system",
            "percent": null
        },
        {
            "name": "Purpura",
            "percent": null
        },
        {
            "name": "Metabolic and nutritional disorders",
            "percent": null
        },
        {
            "name": "Growth retarded",
            "percent": null
        },
        {
            "name": "peripheral edema",
            "percent": null
        },
        {
            "name": "weight gain",
            "percent": null
        },
        {
            "name": "Musculoskeletal system",
            "percent": null
        },
        {
            "name": "Arthralgia",
            "percent": null
        },
        {
            "name": "joint disorder",
            "percent": null
        },
        {
            "name": "myalgia",
            "percent": null
        },
        {
            "name": "myopathy",
            "percent": null
        },
        {
            "name": "Nervous system",
            "percent": null
        },
        {
            "name": "Hyperkinesia",
            "percent": null
        },
        {
            "name": "somnolence",
            "percent": null
        },
        {
            "name": "Psychiatric system",
            "percent": null
        },
        {
            "name": "Depression",
            "percent": null
        },
        {
            "name": "nervousness",
            "percent": null
        },
        {
            "name": "Respiratory system",
            "percent": null
        },
        {
            "name": "Asthma",
            "percent": null
        },
        {
            "name": "epistaxis",
            "percent": null
        },
        {
            "name": "pharyngitis",
            "percent": null
        },
        {
            "name": "rhinitis",
            "percent": null
        },
        {
            "name": "sinusitis",
            "percent": null
        },
        {
            "name": "Integumentary system",
            "percent": null
        },
        {
            "name": "skin and appendages",
            "percent": null
        },
        {
            "name": "Alopecia",
            "percent": null
        },
        {
            "name": "hair disorder",
            "percent": null
        },
        {
            "name": "hirsutism",
            "percent": null
        },
        {
            "name": "leukoderma",
            "percent": null
        },
        {
            "name": "nail disorder",
            "percent": null
        },
        {
            "name": "skin hypertrophy",
            "percent": null
        },
        {
            "name": "Urogenital system",
            "percent": null
        },
        {
            "name": "Cervix disorder",
            "percent": null
        },
        {
            "name": "neoplasm",
            "percent": null
        },
        {
            "name": "dysmenorrhea",
            "percent": null
        },
        {
            "name": "gynecomastia",
            "percent": null
        },
        {
            "name": "breast disorders",
            "percent": null
        },
        {
            "name": "menstrual disorder",
            "percent": null
        },
        {
            "name": "urinary incontinence",
            "percent": null
        },
        {
            "name": "Laboratory abnormality",
            "percent": null
        },
        {
            "name": "Antinuclear antibody present and increased sedimentation rate",
            "percent": null
        },
        {
            "name": "Increased weight",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Altered mood",
            "percent": null
        },
        {
            "name": "Injection site swelling",
            "percent": null
        },
        {
            "name": "Body as a whole",
            "percent": null
        },
        {
            "name": "Asthenia",
            "percent": null
        },
        {
            "name": "cellulitis",
            "percent": null
        },
        {
            "name": "fever",
            "percent": null
        },
        {
            "name": "headache",
            "percent": null
        },
        {
            "name": "injection site reaction",
            "percent": null
        },
        {
            "name": "neoplasm Cardiovascular system",
            "percent": null
        },
        {
            "name": "Angina",
            "percent": null
        },
        {
            "name": "congestive heart failure Digestive system",
            "percent": null
        },
        {
            "name": "Anorexia",
            "percent": null
        },
        {
            "name": "dysphagia",
            "percent": null
        },
        {
            "name": "eructation",
            "percent": null
        },
        {
            "name": "peptic ulcer Hemic and lymphatic system",
            "percent": null
        },
        {
            "name": "Ecchymosis Laboratory abnormalities",
            "percent": null
        },
        {
            "name": "Decreased albumin",
            "percent": null
        },
        {
            "name": "decreased hemoglobin",
            "percent": null
        },
        {
            "name": "hematocrit",
            "percent": null
        },
        {
            "name": "decreased prostatic acid phosphatase",
            "percent": null
        },
        {
            "name": "decreased total protein",
            "percent": null
        },
        {
            "name": "decreased urine specific gravity",
            "percent": null
        },
        {
            "name": "hyperglycemia",
            "percent": null
        },
        {
            "name": "hyperuricemia",
            "percent": null
        },
        {
            "name": "increased BUN",
            "percent": null
        },
        {
            "name": "increased creatinine",
            "percent": null
        },
        {
            "name": "increased liver function tests",
            "percent": null
        },
        {
            "name": "increased phosphorus",
            "percent": null
        },
        {
            "name": "increased platelets",
            "percent": null
        },
        {
            "name": "increased prostatic acid phosphatase",
            "percent": null
        },
        {
            "name": "increased total cholesterol",
            "percent": null
        },
        {
            "name": "increased urine specific gravity",
            "percent": null
        },
        {
            "name": "leukopenia Musculoskeletal system",
            "percent": null
        },
        {
            "name": "Myalgia Nervous system",
            "percent": null
        },
        {
            "name": "Agitation",
            "percent": null
        },
        {
            "name": "insomnia",
            "percent": null
        },
        {
            "name": "sleep disorders",
            "percent": null
        },
        {
            "name": "neuromuscular disorders Respiratory system",
            "percent": null
        },
        {
            "name": "Emphysema",
            "percent": null
        },
        {
            "name": "hemoptysis",
            "percent": null
        },
        {
            "name": "lung edema",
            "percent": null
        },
        {
            "name": "and sputum increased Skin and appendages",
            "percent": null
        },
        {
            "name": "Hair disorder",
            "percent": null
        },
        {
            "name": "skin reaction Urogenital system",
            "percent": null
        },
        {
            "name": "Balanitis",
            "percent": null
        },
        {
            "name": "breast enlargement",
            "percent": null
        },
        {
            "name": "urinary tract infection",
            "percent": null
        },
        {
            "name": "Body as a whole",
            "percent": null
        },
        {
            "name": "Asthenia",
            "percent": null
        },
        {
            "name": "cellulitis",
            "percent": null
        },
        {
            "name": "fever",
            "percent": null
        },
        {
            "name": "headache",
            "percent": null
        },
        {
            "name": "injection site reaction",
            "percent": null
        },
        {
            "name": "neoplasm",
            "percent": null
        },
        {
            "name": "Cardiovascular system",
            "percent": null
        },
        {
            "name": "Angina",
            "percent": null
        },
        {
            "name": "congestive heart failure",
            "percent": null
        },
        {
            "name": "Digestive system",
            "percent": null
        },
        {
            "name": "Anorexia",
            "percent": null
        },
        {
            "name": "dysphagia",
            "percent": null
        },
        {
            "name": "eructation",
            "percent": null
        },
        {
            "name": "peptic ulcer",
            "percent": null
        },
        {
            "name": "Hemic and lymphatic system",
            "percent": null
        },
        {
            "name": "Ecchymosis",
            "percent": null
        },
        {
            "name": "Laboratory abnormalities",
            "percent": null
        },
        {
            "name": "Decreased albumin",
            "percent": null
        },
        {
            "name": "decreased hemoglobin",
            "percent": null
        },
        {
            "name": "hematocrit",
            "percent": null
        },
        {
            "name": "decreased prostatic acid phosphatase",
            "percent": null
        },
        {
            "name": "decreased total protein",
            "percent": null
        },
        {
            "name": "decreased urine specific gravity",
            "percent": null
        },
        {
            "name": "hyperglycemia",
            "percent": null
        },
        {
            "name": "hyperuricemia",
            "percent": null
        },
        {
            "name": "increased BUN",
            "percent": null
        },
        {
            "name": "increased creatinine",
            "percent": null
        },
        {
            "name": "increased liver function tests",
            "percent": null
        },
        {
            "name": "increased phosphorus",
            "percent": null
        },
        {
            "name": "increased platelets",
            "percent": null
        },
        {
            "name": "increased prostatic acid phosphatase",
            "percent": null
        },
        {
            "name": "increased total cholesterol",
            "percent": null
        },
        {
            "name": "increased urine specific gravity",
            "percent": null
        },
        {
            "name": "leukopenia",
            "percent": null
        },
        {
            "name": "Musculoskeletal system",
            "percent": null
        },
        {
            "name": "Myalgia",
            "percent": null
        },
        {
            "name": "Nervous system",
            "percent": null
        },
        {
            "name": "Agitation",
            "percent": null
        },
        {
            "name": "insomnia",
            "percent": null
        },
        {
            "name": "sleep disorders",
            "percent": null
        },
        {
            "name": "neuromuscular disorders",
            "percent": null
        },
        {
            "name": "Respiratory system",
            "percent": null
        },
        {
            "name": "Emphysema",
            "percent": null
        },
        {
            "name": "hemoptysis",
            "percent": null
        },
        {
            "name": "lung edema",
            "percent": null
        },
        {
            "name": "and sputum increased",
            "percent": null
        },
        {
            "name": "Skin and appendages",
            "percent": null
        },
        {
            "name": "Hair disorder",
            "percent": null
        },
        {
            "name": "skin reaction",
            "percent": null
        },
        {
            "name": "Urogenital system",
            "percent": null
        },
        {
            "name": "Balanitis",
            "percent": null
        },
        {
            "name": "breast enlargement",
            "percent": null
        },
        {
            "name": "urinary tract infection",
            "percent": null
        },
        {
            "name": "Neuromuscular disorders",
            "percent": null
        },
        {
            "name": "Skin reaction",
            "percent": null
        },
        {
            "name": "Insomnia",
            "percent": null
        },
        {
            "name": "sleep disorders",
            "percent": null
        },
        {
            "name": "Asthenia",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Vertigo",
            "percent": null
        },
        {
            "name": "Respiratory disorders",
            "percent": null
        },
        {
            "name": "Body as a whole",
            "percent": null
        },
        {
            "name": "Enlarged abdomen",
            "percent": null
        },
        {
            "name": "fever Cardiovascular system",
            "percent": null
        },
        {
            "name": "Arrhythmia",
            "percent": null
        },
        {
            "name": "bradycardia",
            "percent": null
        },
        {
            "name": "heart failure",
            "percent": null
        },
        {
            "name": "hypertension",
            "percent": null
        },
        {
            "name": "hypotension",
            "percent": null
        },
        {
            "name": "varicose vein Digestive system",
            "percent": null
        },
        {
            "name": "Anorexia",
            "percent": null
        },
        {
            "name": "duodenal ulcer",
            "percent": null
        },
        {
            "name": "increased appetite",
            "percent": null
        },
        {
            "name": "thirst",
            "percent": null
        },
        {
            "name": "dry mouth Hemic and lymphatic system",
            "percent": null
        },
        {
            "name": "anemia",
            "percent": null
        },
        {
            "name": "lymphedema Laboratory abnormalities",
            "percent": null
        },
        {
            "name": "Increased BUN",
            "percent": null
        },
        {
            "name": "hyperglycemia",
            "percent": null
        },
        {
            "name": "hyperlipidemia",
            "percent": null
        },
        {
            "name": "hyperphosphatemia",
            "percent": null
        },
        {
            "name": "abnormal liver function tests",
            "percent": null
        },
        {
            "name": "increased PT",
            "percent": null
        },
        {
            "name": "increased PTT",
            "percent": null
        },
        {
            "name": "decreased platelets",
            "percent": null
        },
        {
            "name": "decreased potassium",
            "percent": null
        },
        {
            "name": "increased WBC Metabolic and nutritional disorders",
            "percent": null
        },
        {
            "name": "dehydration",
            "percent": null
        },
        {
            "name": "edema Nervous system",
            "percent": null
        },
        {
            "name": "Anxiety",
            "percent": null
        },
        {
            "name": "delusions",
            "percent": null
        },
        {
            "name": "depression",
            "percent": null
        },
        {
            "name": "hypesthesia",
            "percent": null
        },
        {
            "name": "libido decreased",
            "percent": null
        },
        {
            "name": "nervousness",
            "percent": null
        },
        {
            "name": "paresthesia Respiratory system",
            "percent": null
        },
        {
            "name": "Epistaxis",
            "percent": null
        },
        {
            "name": "pharyngitis",
            "percent": null
        },
        {
            "name": "pleural effusion",
            "percent": null
        },
        {
            "name": "pneumonia Special senses",
            "percent": null
        },
        {
            "name": "Abnormal vision",
            "percent": null
        },
        {
            "name": "amblyopia",
            "percent": null
        },
        {
            "name": "dry eyes",
            "percent": null
        },
        {
            "name": "tinnitus Urogenital system",
            "percent": null
        },
        {
            "name": "Gynecomastia",
            "percent": null
        },
        {
            "name": "impotence",
            "percent": null
        },
        {
            "name": "penis disorders",
            "percent": null
        },
        {
            "name": "testis disorders",
            "percent": null
        },
        {
            "name": "Body as a whole",
            "percent": null
        },
        {
            "name": "Enlarged abdomen",
            "percent": null
        },
        {
            "name": "fever",
            "percent": null
        },
        {
            "name": "Cardiovascular system",
            "percent": null
        },
        {
            "name": "Arrhythmia",
            "percent": null
        },
        {
            "name": "bradycardia",
            "percent": null
        },
        {
            "name": "heart failure",
            "percent": null
        },
        {
            "name": "hypertension",
            "percent": null
        },
        {
            "name": "hypotension",
            "percent": null
        },
        {
            "name": "varicose vein",
            "percent": null
        },
        {
            "name": "Digestive system",
            "percent": null
        },
        {
            "name": "Anorexia",
            "percent": null
        },
        {
            "name": "duodenal ulcer",
            "percent": null
        },
        {
            "name": "increased appetite",
            "percent": null
        },
        {
            "name": "thirst",
            "percent": null
        },
        {
            "name": "dry mouth",
            "percent": null
        },
        {
            "name": "Hemic and lymphatic system",
            "percent": null
        },
        {
            "name": "anemia",
            "percent": null
        },
        {
            "name": "lymphedema",
            "percent": null
        },
        {
            "name": "Laboratory abnormalities",
            "percent": null
        },
        {
            "name": "Increased BUN",
            "percent": null
        },
        {
            "name": "hyperglycemia",
            "percent": null
        },
        {
            "name": "hyperlipidemia",
            "percent": null
        },
        {
            "name": "hyperphosphatemia",
            "percent": null
        },
        {
            "name": "abnormal liver function tests",
            "percent": null
        },
        {
            "name": "increased PT",
            "percent": null
        },
        {
            "name": "increased PTT",
            "percent": null
        },
        {
            "name": "decreased platelets",
            "percent": null
        },
        {
            "name": "decreased potassium",
            "percent": null
        },
        {
            "name": "increased WBC",
            "percent": null
        },
        {
            "name": "Metabolic and nutritional disorders",
            "percent": null
        },
        {
            "name": "dehydration",
            "percent": null
        },
        {
            "name": "edema",
            "percent": null
        },
        {
            "name": "Nervous system",
            "percent": null
        },
        {
            "name": "Anxiety",
            "percent": null
        },
        {
            "name": "delusions",
            "percent": null
        },
        {
            "name": "depression",
            "percent": null
        },
        {
            "name": "hypesthesia",
            "percent": null
        },
        {
            "name": "libido decreased",
            "percent": null
        },
        {
            "name": "nervousness",
            "percent": null
        },
        {
            "name": "paresthesia",
            "percent": null
        },
        {
            "name": "Respiratory system",
            "percent": null
        },
        {
            "name": "Epistaxis",
            "percent": null
        },
        {
            "name": "pharyngitis",
            "percent": null
        },
        {
            "name": "pleural effusion",
            "percent": null
        },
        {
            "name": "pneumonia",
            "percent": null
        },
        {
            "name": "Special senses",
            "percent": null
        },
        {
            "name": "Abnormal vision",
            "percent": null
        },
        {
            "name": "amblyopia",
            "percent": null
        },
        {
            "name": "dry eyes",
            "percent": null
        },
        {
            "name": "tinnitus",
            "percent": null
        },
        {
            "name": "Urogenital system",
            "percent": null
        },
        {
            "name": "Gynecomastia",
            "percent": null
        },
        {
            "name": "impotence",
            "percent": null
        },
        {
            "name": "penis disorders",
            "percent": null
        },
        {
            "name": "testis disorders",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "nausea",
            "percent": null
        },
        {
            "name": "General disorders and administration site conditions",
            "percent": null
        },
        {
            "name": "Asthenia",
            "percent": null
        },
        {
            "name": "gait disturbance",
            "percent": null
        },
        {
            "name": "injection site abscess sterile",
            "percent": null
        },
        {
            "name": "injection site hematoma",
            "percent": null
        },
        {
            "name": "injection site induration",
            "percent": null
        },
        {
            "name": "injection site warmth",
            "percent": null
        },
        {
            "name": "irritability",
            "percent": null
        },
        {
            "name": "Metabolic and nutritional disorders",
            "percent": null
        },
        {
            "name": "Decreased appetite",
            "percent": null
        },
        {
            "name": "obesity",
            "percent": null
        },
        {
            "name": "Musculoskeletal and connective tissue disorders",
            "percent": null
        },
        {
            "name": "Musculoskeletal pain",
            "percent": null
        },
        {
            "name": "pain in extremity",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Psychiatric disorders",
            "percent": null
        },
        {
            "name": "Crying",
            "percent": null
        },
        {
            "name": "tearfulness",
            "percent": null
        },
        {
            "name": "Respiratory",
            "percent": null
        },
        {
            "name": "thoracic",
            "percent": null
        },
        {
            "name": "and mediastinal disorders",
            "percent": null
        },
        {
            "name": "Cough",
            "percent": null
        },
        {
            "name": "Skin and SC tissue disorders",
            "percent": null
        },
        {
            "name": "Hyperhidrosis",
            "percent": null
        },
        {
            "name": "Vascular disorders",
            "percent": null
        },
        {
            "name": "Pallor",
            "percent": null
        },
        {
            "name": "Allergic Reactions",
            "percent": null
        },
        {
            "name": "Anaphylactic",
            "percent": null
        },
        {
            "name": "rash",
            "percent": null
        },
        {
            "name": "urticaria",
            "percent": null
        },
        {
            "name": "and photosensitivity reactions",
            "percent": null
        },
        {
            "name": "General",
            "percent": null
        },
        {
            "name": "Chest pain",
            "percent": null
        },
        {
            "name": "weight increase",
            "percent": null
        },
        {
            "name": "weight decrease",
            "percent": null
        },
        {
            "name": "decreased appetite",
            "percent": null
        },
        {
            "name": "fatigue",
            "percent": null
        },
        {
            "name": "Laboratory abnormalities",
            "percent": null
        },
        {
            "name": "Decreased WBC",
            "percent": null
        },
        {
            "name": "Metabolic",
            "percent": null
        },
        {
            "name": "Diabetes mellitus",
            "percent": null
        },
        {
            "name": "Musculoskeletal and connective tissue",
            "percent": null
        },
        {
            "name": "Arthralgia",
            "percent": null
        },
        {
            "name": "epiphysiolysis",
            "percent": null
        },
        {
            "name": "muscle spasms",
            "percent": null
        },
        {
            "name": "myalgia",
            "percent": null
        },
        {
            "name": "Neurologic",
            "percent": null
        },
        {
            "name": "Neuropathy peripheral",
            "percent": null
        },
        {
            "name": "convulsion",
            "percent": null
        },
        {
            "name": "paralysis",
            "percent": null
        },
        {
            "name": "insomnia",
            "percent": null
        },
        {
            "name": "Psychiatric",
            "percent": null
        },
        {
            "name": "Emotional lability",
            "percent": null
        },
        {
            "name": "depression",
            "percent": null
        },
        {
            "name": "rare reports of suicidal ideation and attempt",
            "percent": null
        },
        {
            "name": "has been reported for GnRH agonists in pediatric patients treated for CPP",
            "percent": null
        },
        {
            "name": "Skin and SC tissue",
            "percent": null
        },
        {
            "name": "Injection",
            "percent": null
        },
        {
            "name": "site reactions",
            "percent": null
        },
        {
            "name": "eg",
            "percent": null
        },
        {
            "name": "induration and abscess",
            "percent": null
        },
        {
            "name": "flushing",
            "percent": null
        },
        {
            "name": "hyperhidrosis",
            "percent": null
        },
        {
            "name": "Reproductive system",
            "percent": null
        },
        {
            "name": "Vaginal bleeding",
            "percent": null
        },
        {
            "name": "breast enlargement",
            "percent": null
        },
        {
            "name": "Vascular",
            "percent": null
        },
        {
            "name": "Hypertension",
            "percent": null
        },
        {
            "name": "hypotension",
            "percent": null
        },
        {
            "name": "Respiratory",
            "percent": null
        },
        {
            "name": "Dyspnea",
            "percent": null
        },
        {
            "name": "Pseudotumor cerebri",
            "percent": null
        },
        {
            "name": "idiopathic intracranial hypertension",
            "percent": null
        },
        {
            "name": "Pituitary apoplexy occurred within",
            "percent": null
        },
        {
            "name": "weeks of the first dose",
            "percent": null
        },
        {
            "name": "and some within the first hour",
            "percent": null
        },
        {
            "name": "patients presented as sudden headache",
            "percent": null
        },
        {
            "name": "vomiting",
            "percent": null
        },
        {
            "name": "visual changes",
            "percent": null
        },
        {
            "name": "ophthalmoplegia",
            "percent": null
        },
        {
            "name": "altered mental status",
            "percent": null
        },
        {
            "name": "and sometimes cardiovascular collapse",
            "percent": null
        },
        {
            "name": "immediate medical attention has been required",
            "percent": null
        },
        {
            "name": "Nervous System",
            "percent": null
        },
        {
            "name": "Convulsions",
            "percent": null
        },
        {
            "name": "Respiratory System",
            "percent": null
        },
        {
            "name": "Interstitial lung disease",
            "percent": null
        },
        {
            "name": "Cardiovascular system",
            "percent": null
        },
        {
            "name": "Hypotension",
            "percent": null
        },
        {
            "name": "myocardial infarction",
            "percent": null
        },
        {
            "name": "pulmonary embolism",
            "percent": null
        },
        {
            "name": "Respiratory",
            "percent": null
        },
        {
            "name": "thoracic and mediastinal disorder",
            "percent": null
        },
        {
            "name": "Interstitial lung disease",
            "percent": null
        },
        {
            "name": "Hepatobiliary disorder",
            "percent": null
        },
        {
            "name": "Serious drug",
            "percent": null
        },
        {
            "name": "induced liver injury",
            "percent": null
        },
        {
            "name": "Hemic and lymphatic system",
            "percent": null
        },
        {
            "name": "Decreased WBC",
            "percent": null
        },
        {
            "name": "Central",
            "percent": null
        },
        {
            "name": "peripheral nervous system",
            "percent": null
        },
        {
            "name": "Convulsion",
            "percent": null
        },
        {
            "name": "peripheral neuropathy",
            "percent": null
        },
        {
            "name": "spinal fracture",
            "percent": null
        },
        {
            "name": "paralysis",
            "percent": null
        },
        {
            "name": "Endocrine system",
            "percent": null
        },
        {
            "name": "Diabetes",
            "percent": null
        },
        {
            "name": "Musculoskeletal system",
            "percent": null
        },
        {
            "name": "Tenosynovitis",
            "percent": null
        },
        {
            "name": "like symptoms",
            "percent": null
        },
        {
            "name": "Urogenital system",
            "percent": null
        },
        {
            "name": "Prostate pain",
            "percent": null
        }
    ]
}